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ABSTRACT
Human papillomavirus (HPV) belonging to Papillomaviridae (family of Papillomavirus). HPV infection causes various types of disorders and diseases 
including cervical, vaginal, anal, penile, oropharyngeal, and lung cancer also cancer in head and neck along with some malignant and benign warts. 
HPV also found to be responsible for respiratory papillomatosis. Epidermodysplasia verruciformis, an orphan disease termed as tree man disease, is 
also occurred by the HPV infection. Vaccines show benefit nowadays. Some surgery and adjuvant therapy is also showing response in the treatment of 
HPV caused cancers. In this abstract, we summarized the types, structures, genomic organization, mode of transmission of the virus along with type 
of infections, and protection and modern treatment approaches.
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INTRODUCTION
The human papillomavirus (HPV) belongs to Papillomaviridae (family 
of papillomavirus) [1,2]. Taxonomically, Papillomaviridae is a virus 
family having the members of non-enveloped DNA viruses, on the whole 
called as Papillomaviruses [3]. Lots of species of papillomaviruses are 
there which are traditionally attributed as “types.” Papillomaviruses 
can cause infection in most of the mammals [3] along with some other 
amniotes such as snakes, birds, and turtles [4-8].
EVOLUTION OF PAPILLOMAVIRUS
The word papilloma is the combination of two words that is Papilla and 
Oma. Papilla is a Latin word means a rounded small protuberance on an 
organ or on a part of body (ex-papilla on tongue) and Oma is also a Latin 
word stands for any abnormal growth such as tumors (ex-carcinoma). 
Hence, grossly we can say that the viruses which cause papilloma 
infection to humans are termed as HPV.
Papillomavirus evolution is presumed to be slower than many other 
types of , but this cannot be proved due to lack of experimental 
measurements. Codivergence with the host animal is one of the 
hypotheses in the evolution of papillomavirus. The other aspects 
of the evolution of papillomavirus are viral sorting, within host 
virus duplication, and adaptation of virus after switching of host 
[9]; for example, HPV16 reflected migration of human beings as it 
codiverged with human in whole earth showed variations in different 
regions [10,11]. The HPV-13 has a sequence which is closely similar a 
bonobo’s (pygmy chimpanzees) papillomavirus [12] because HPV13 
had changed a little bit for the past 6 or some more million years from 
when human and bonobos were diverged [11].
MORPHOLOGY OF HPV
The HPV is a DNA virus (non-enveloped). The DNA is having double 
strand which is arranged in circular manner. The DNA is having 
almost 8000 base pairs and packed with histone protein. The capsid 
is not covered with lipid membrane that is why it is termed as non-
enveloped. The capsid (55–60 nm) is made up of proteins (L1 and 
L2). Geometrically, this capsid is regular and also symmetric-like 
icosahedrons. The capsomeres (unit of capsid) made up of proteins 
arranged in pentameric order. It also was observed that the capsid of 
many papillomavirus is made up of 72 capsomeres (Fig. 1) [13].
GENOMIC ORGANIZATION AND GENE EXPRESSION
The HPV has a circular double-stranded DNA as its genetic material. Its 
genome is comprises of two regions, early (E) and late (L). Early region 
has the coding regions which are commonly known as open reading 
frame (ORF) and the late region codes for 2 proteins, L1 and L2. These 
2 proteins make its capsid. ORF is the region which codes for proteins 
or polypeptides. In spite of having two DNA strands, all the ORFs are 
situated on only one strand. The virus consists of six numbers of ORFs 
such as E1, E2, E4, E5, E6, and E7. Fig. 2 depicts the genetic organization 
of a papillomavirus [14].
Promoter site of its gene is activated only after infect the host cell. 
After doing infection to the host cell, the DNA of the papillomavirus 
goes into transcription (DNA to RNA). After transcription, primary 
mRNA is produce which contains all the ORFs. For these characteristics, 
this mRNA can code more than one protein or polypeptides (because 
it has six ORFs and all of those are able to do coding for proteins or 
polypeptides). This type of characterized RNA is generally known as 
polycistronic RNA [14].
This polycistronic RNA consists of two introns (non-coding sequence of 
DNA) and three exons (coding sequence of DNA). After the production 
of this RNA, it undergoes post-transcriptional modification in alteration 
mechanism more specifically splicing and produces multiple mRNAs. 
Splicing is a mechanism where the introns are removed. However, in 
HPV16, an intron of E6 ORF does not remove and endure intact after 
splicing. This intron codes E6 oncoprotein in translation and also 
expresses E7 oncoprotein. The viral genome s E2 ORF and enters into 
host genome, and thus, repression of E2 on both E6 and E7 is prevented. 
When this viral genome enters into host genome, the expressions 
obtained by E6 and E7 are increased, which help cells to proliferate and 
lead to malignancy [15].
The promoter site of late region (L) activates when DNA replication 
(DNA to DNA) takes place. After transcription, late region also produces 
polycistronic messenger RNA. This mRNA also consists of three exons 
and two introns. In transcription process, this mRNA codes L1 and L2 
protein which is essential for the formation of capsid of this virus. Post-
© 2018 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2018.v11i6.24233
Review Article
13
Asian J Pharm Clin Res, Vol 11, Issue 6, 2018, 12-16
 Chakraborty et al. 
transcriptional modification in late region is also splicing, and in this 
case, it is regulated by some splicing factors of host and cis-elements 
of RNA.
The E6 ORF codes E6 protein (sometimes E7 also). This protein attached 
with p53 protein and inactivates it. The p53 protein is coded by p53 gene 
(tumor suppressor gene and also a negative regulator for cell cycle). 
The E6 protein makes p53 protein to bind with ubiquitin (a regulatory 
protein) and degrades p53 protein by ubiquitin ligase pathway and 
leads p53 for lyses by proteasome. The p21 is another protein under 
the control of p53 which inactivates cyclin D/Cdk4 complex (a positive 
regulator of cell cycle) and prevents phosphorylation of Rb protein (a 
protein holds the cell cycle in check while it is hypophosphorylated). 
As a result, a cell gets arrested. The p53 protein also plays a key role 
in mitochondrial pathway of apoptosis (programmed cell death). 
When DNA gets damaged, p53 protein plays most important role in the 
formation of apoptosome, caspase 9, and then caspase 3 and leads to 
cell death. Hence, by inactivating p53 protein, E6 protein inhibits cell 
death as well as increases cell proliferation [15].
VIROLOGY
The HPV cannot bind with living cells. It can only infect epithelial cell as 
it is dead cell. More specifically, only the basal cells of stratified epithelial 
tissue are infected by HPV. This virus replicates only in this tissue. 
This virus infects the host cell (epithelial) by microsized abrasions or 
other trauma in epithelial tissue, and as a result, some segments of 
basal membrane gets exposed and the virus can easily enters into host 
cell [16]. As this virus is a non-enveloped virus, it induces antibody 
production into host organism. However, those antibodies cannot 
neutralize the viruses because they still remain in the basement 
membrane as well as cell surface. The keratinocytes of stratified 
epithelium tissue is infected by this virus. HPV has laminis and alpha 
integrins receptors, which helps it to enter into host keratinocytes by 
endocytosis (caveolin-mediated endocytosis and/or clathrin-mediated 
endocytosis). After entering into keratinocyte, the virus genome is 
moved to the nucleus of keratinocytes, but the transportation pathway 
is still unknown. After that, it makes 10–200 numbers of its copy per 
host cell. This virus cannot do oxidative lyses of host cell, instead of 
that they release after the degeneration of the desquamated cells [15]. 
Papillomavirus can survive without host for many months in a low 
temperature, which indicates that HPV infection can also be caused by 
other than skin contact like sharing objects [15].
MODE OF TRANSMISSION
The HPV infection occurs by the HPV [1]. Some of the HPV infection 
does not show any symptoms and can be cured spontaneously [16]. This 
infection causes warts or sometimes precancerous lesions. This kind 
of precancerous lesions can lead to cancers, for example, vaginal, anal, 
cervical, oropharyngeal, and penile cancers [17]. HPV18 and HPV16 are 
found to be responsible in 70% of cases of cervical cancers, whereas 
HPV11 and HPV6 are responsible for respiratory papillomatosis and 
genital warts [16]. There are various ways by which HPV infections can 
occur (Table 1). These are summarized as follows.
Sexual contact
Sexual contact is one of the major risk factors for HPV infections [18]. 
From the known 120 species of papillomaviruses, 51 types along with 
their subtypes are found to be responsible for the infection of mucosa 
layers of genital areas [19]. Among them, 15 types are grouped as “high 
risk” such as 18, 31, 16, 33, 39, 35, 52, 51, 45, 58, 59, 56, 82, 68, and 
73. The 3 types are categorized as “moderate risk” such as 66, 26, and 
53. The 12 types are grouped as “lower risk” such as 81, 61, 11, 70, 
40, 44, 6, 43, 72, 54, CP6108, and 70 [20].  First sexual intercourse in 
an early age, multiple sexual partners, cunnilingus, and/or fellatio with 
multiple partners and unhygienic habits are the main causes of HPV 
infection [16].
PERINATAL
During childbirth, HPV can be transmitted to child from the mother. 
However, in this case, the infection does not show any appearance 
quickly as this virus can hide them for a longer time. Juvenile onset 
recurrent respiratory papillomatosis (JORRP) is produced by HPV11 
and HPV6 in neonates. The JORRP is seen in 2 neonates among 
1,000,000 neonates, and in this term, it is said that it is rare disease. 
Table 1: Risk factors, infection, transmission mode, severity, and preventive measures of HPV
Risk factors Infection Transmission mode Severity Preventive measure
Multiple sexual partners, feeble 
immunity system, age, broken 
skin, skin contact, tobacco use
Cancers  
(cervical, genital, oropharyngeal, 
lungs, head and neck), warts  
(common, planter, flat, 







In 2012, worldwide, 5,30,000 
new cases of cervical cancer 
were reported. Alongside, 
270000 incident of mortality 




Fig. 1: The three-dimensional structure of a general type of 
Papilloma virus
Fig. 2: Genetic organization of Papilloma virus
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However, the rate of JORRP increases if the mother has genital warts 
during childbirth though it is very less (<1%) [21].
Blood
Previously, it was believed that HPV infection cannot transmit by blood. 
However, in 2005, a study was done in 57 pediatric patients (naive in 
sexual contact) who were transfusion acquired or vertical HPV infected, 
and among 8 of them, HPV16 was detected in their blood samples [22]. 
Although in blood, the existence of the DNA of HPV cannot prove that 
the person is infected by HPV. To prove this, in 2009, a test was done 
with 180 healthy male’s blood sample and 15 among the samples were 
found one or more than one type of HPV [23]. The conclusion about this 
topic is yet not decided whether HPV is transmitted through blood or 
not [24].
Hands
The HPV infection can be spread among sexual partners or the same 
person through their genitals and hands. A study done with 25 couples 
for 7 months tested on their hands and genitals. The outcome of this 
study demonstrated that 2 among 25 couples infected by HPV (high 
risk). The hands of females infected for the genital infections of the men. 
In 2 couples, the hands of women infected men’s genitals. In one couple, 
the man’s hand is infected by this woman’s genitals. In 2 couples, each 
of them infects their own hand [25]. This experiment showed that hand 
was not the primary source of HPV infection, but hands played a key 
role in this infection. However, non-sexual contact by hand had very 
little or generally no role in this HPV infection.
Sharing object
The object which is contaminated with HPV can cause HPV infection in 
case of sharing [26]. Except sexual contact, other possible routes are not 
common for genital HPV infection in female. However, sharing common 
things such as toilet seat cannot cause HPV infection.
Surgery
It has been documented that HPV infection can be spread by inhalation 
viral noxious substance by any person in the surgery room during 
laser ablation on condyloma or electrocautery. A surgeon infected by 
HPV during laser ablation on anogenital condyloma can suffer from 
laryngeal papillomatosis [27].
TYPES OF INFECTIONS CAUSED BY HPV
Cancer
Cancer in vagina, anus, vulva, penis, and most important in cervix is 
cased due to HPV infections [16,17]. The HPV16, HPV18, HPV31, and 
HPV45 are known to be highly risky for all the types of previously said 
cancers. Some infected patient’s immune system does not respond after 
this infection and this will enhance the growth of cancers. Additional 
effects such as cigarette smoking enhance the chance of getting cancer 
associated with HPV [28]. The types of cancers associated with HPV 
infections are as follows.
•	 Cervical cancer
HPV infection is the foremost cause of cervical cancer, which is the 
leading cancer in India and second utmost common cancer worldwide. 
Approximately, all the types of cervical cancers are caused due to the 
infection of HPV. In 70% of cervical cancers, the HPV18 and HPV16 
infections are found to be responsible [16]. About 41–54% cervical 
cancers are found to be occurring for the HPV16, the one strain which is 
mostly malignant [29]. HPV16 is also responsible for anal, vaginal, head 
and neck, vulvar, and also penile cancers [30]. In general, in cervical 
cancer, the rate of transformation of normal cells into cancerous 
cells is relatively slower. The persons infected with HPV more than a 
decade or a much longer duration are more prone to having cervical 
cancers [21,31].
•	 Genital cancer
Penile cancer and anal cancer also caused by HPV when transmitted 
sexually. The risk for getting anal cancer with the HPV is higher for the 
bisexual and homosexual men [32,33]. However, one study showed that 
there was no difference between homosexual men and heterosexual 
men in terms of HPV infection rate [33].
•	 Oropharyngeal cancer
Oral HPV infection causes oropharyngeal cancer. This is also termed as 
HPV+OPC (HPV16+ oropharyngeal cancer). This type of cancer is also 
relatively slowly showed symptoms such as cervical cancers, and risk 
is shown after 15 years from when that person infected by HPV [34]. 
Tobacco increases the risk of retrogression of disease with HPV+POC 
patients [35].
•	 Lung cancer
The HPV can cause malignant as well as benign tumors in the upper 
part of respiratory tract. Antibodies for HPV are found in many cases 
of lung cancers [36]. The expression of the proteins (structural) of 
HPV shows the presence of HPV in bronchial cancers in in vitro and 
immunohistochemistry studies [37].
•	 Cancer on head and neck
The HPV16 and HPV18 are found to be responsible for head-and-neck 
cancers. HPV infection spread by sexual contacts is increased the risk 
of oral cancers, tonsil cancers, oropharyngeal cancer as well as upper 
throat and mouth cancer in non-smokers also [38]. Oropharyngeal 
cancer caused by HPV termed as HPV+OPC (HPV16+ oropharyngeal 
cancer) [34].
WARTS
Warts are generally found with all the types of HPV infections. Non-
cancerous warts are very common in people. HPV2, HPV27, and HPV57 
cause warts while types 2, 1, and 63 do not cause warts [39]. The types 
of warts are common warts (found in feet, hands, knees, and elbows), 
plantar warts (found in feet soles), flat warts (found in foreheads, faces, 
and arms), and periangular warts (found in fingernails around cuticles 
and nails also).
Genital warts associated with HPV are one of the very usual sexually 
transmitted diseases. More than 90% of cases of the all types of genital 
warts are caused by HPV6 and HPV11 [40]. Infection in anus and 
genitals caused by HPV (40 types) is transmitted by sexual activities 
[41]. This type of infection leads to warts in genital areas. It is found 
that most of the population gets HPV infection at least once in their life. 
It is not obvious that genital warts lead to cancers, some cured without 
any kind of medications or attentions [41].
RESPIRATORY PAPILLOMATOSIS
The presence of warts in respiratory tract including larynx or other 
parts is termed as respiratory papillomatosis [21]. HPV6 and HPV11 
cause respiratory papillomatosis. Inhalation is one of the aspects for 
the spreading of respiratory papillomatosis. A surgeon infected by 
HPV during laser ablation on anogenital condyloma can suffer from 
laryngeal papillomatosis [27].
EPIDERMODYSPLASIA VERRUCIFORMIS
Epidermodysplasia verruciformis is also termed as tree man disease 
and is an abnormality in autosomal recessive gene along with HPV 
infection leads to high risk skin carcinoma [42]. The patient’s immune 
system fails to check HPV and produce keratin in an excess level, which 
causes horns in the skin.
PREVENTIVE MEASURES
Vaccines
Three types of vaccines are made to prevent HPV infections. They are 
Gardasil 9, cervarix, and Gardasil. They are able to protect form HPV16 
and HPV18, while Gardasil (a recombinant vaccine) is able to protect 
form HPV6 and HPV11 also. Cervarix (bivalent type) is produced by VLP 
(virus like particles which are look like virus but do not contain viral 
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genome) from the protein found in capsid (L1). The Gardasil 9 is able to 
protect from HPV16, HPV18, HPV31, HPV45, HPV52, HPV58, HPV6, and 
HPV11; hence, above 90% of genital cancers (cervical, anal, vaginal, and 
vulvar cancers) can be protected with the help of these vaccines [43]. 
These vaccines show very little effects on the women who have already 
exposed to HPV16 and HPV18. Hence, women who are sexually naives 
are recommended for vaccination [44].
Condoms
The CDCP suggests that the use of condoms is beneficial to decrease 
the risk associated to the HPV infection. Female condoms are found 
to be much more acceptable in terms of the reduction of HPV contact. 
However, condom cannot give too much protection as HPV can transmit 
through any area which is not covered by condoms like any mucosal 
surface or infected area of skin [45].
Disinfectants
This virus can be killed by some disinfectant though it is very difficult 
to kill it. Exposed it to 90% ethanol (for 1 min), 30% savlon, 2% 
glutaraldehyde, and1% sodium hypochlorite can be beneficial. This 
virus can be demolished at 100°C though it is resistance in temperature 
and drying. It can also be killed by ultraviolet radiations [46].
CONCLUSION AND FUTURE PERSPECTIVES
Treatment in HPV infection is still not available [47]. Only by giving 
vaccine, we can prevent HPV infection but the persons already exposed 
to HPV cannot be cured till now. Recent study shows that HPV-positive 
oropharyngeal cancers can be cured with the help of surgery as well as 
adjuvant therapy [48]. Antiretroviral therapy is also found to be helpful 
in the case of anal and cervical cancers [49].
The HPV infection is one of the major concerns nowadays. The virus can 
be spread by very common routes such as hand contact, sharing objects, 
sexual contacts, blood, and most surprisingly through inhalation also 
[50]. Protection from this virus is available only by vaccination. On the 
clinical trials (phase II) of CervarixTM, the efficacy of preventing HPV18 
and 16 infection was 92% while efficacy in the prevention of obstinate 
infection was 100%. On the other hand, the efficacy of preventing HPV 
6, 11, 16, and 18 with GardasilTM was 90% in Phase II and 100% (for 
HPV 16 and 18) in phase III clinical trial [51,52]. However, vaccination 
also associated with many limitations like it should be given within 13–
19 before any kind of sexual exposure though it can be spread through 
hand contact also. All kind of HPV cannot protect by this vaccines. Only 
a few can be protected. The use of condoms shows very little protection. 
Treatment is also unavailable till date. However, recent studies show 
some hope to as through surgery and adjuvant therapy or antiretroviral 
therapy is found to cure HPV-positive oropharyngeal, anal, and cervical 
cancers.
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